Skip to main content

Day: January 6, 2022

Royalty Pharma Announces 12% Dividend Increase

NEW YORK, Jan. 06, 2022 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2022 of $0.19 per Class A share, reflecting a 12% increase in the company’s quarterly dividend over the previous quarter’s dividend. The dividend will be paid on March 15, 2022, to shareholders of record at the close of business on February 18, 2022. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties...

Continue reading

Security National Financial Corp. Acquires Rivera Family Funeral Homes and Cemetery

SALT LAKE CITY, Jan. 06, 2022 (GLOBE NEWSWIRE) — Security National Financial Corporation (NASDAQ: SNFCA) announced today the closing of its purchase of the Rivera Family Funeral Homes and Santa Fe Memorial Gardens (“Rivera”). Rivera is a New Mexico based death care service provider with four mortuaries and one cemetery located in northern New Mexico. Rivera serves approximately 1,300 families annually. Tim Rivera, founder of Rivera, said, “We are excited to join an organization that shares the same values and high standards as our family. Together, we are committed to continuing to provide the families of New Mexico with the premier products and services they have come to expect from our organization.” Adam G. Quist, Vice President of Security National, commented, “We are honored that Tim Rivera and the Rivera family have chosen...

Continue reading

PHBI Pharmagreen Announces Affirmed MOU to Acquire Licensed California Cannabis Company

CARSON CITY, NV, Jan. 06, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Pharmagreen Biotech, Inc., (OTCQB: PHBI), today announced an affirmed memorandum of understanding (MOU) to acquire Long Valley Farms LLC, a California-based cannabis company.  The acquisition includes land, infrastructure, and a Cannabis cultivation license for the operation of a cannabis business in the State of California. This acquisition is a strategic component of Pharmagreen’s strategy to convert the revenue potential of its proven proprietary cannabis tissue culture technology, Chibafreen, into realized revenue. As part of its vertical growth strategy, Long Valley Farms will immediately commence applying for nursery, distribution, non-volatile extraction and retail Cannabis licenses with the regulatory bodies in the state of California. Learn more about...

Continue reading

RPT Realty Announces $791 Million of Investment Activity in 2021

NEW YORK, Jan. 06, 2022 (GLOBE NEWSWIRE) — RPT Realty (NYSE:RPT) (“RPT” or the “Company”) announced today transaction activity for the quarter and year ended December 31, 2021. During the fourth quarter 2021, through its three strategic investment platforms, the Company closed on the acquisition of three multi-tenant open-air shopping centers with a contract value of $173.0 million. The Company, through its RGMZ net lease platform also acquired $73.2 million of single-tenant net lease assets, all of which were parceled from existing RPT multi-tenant shopping centers. Additionally, the Company closed on the sale of Market Plaza and Webster Place in the Chicago market for a combined contract value of $59.5 million. For the full year 2021, through its three strategic investment platforms, the Company closed on 11 multi-tenant acquisitions...

Continue reading

Northern Technologies International Corporation Reports Financial Results For First Quarter Fiscal 2022

MINNEAPOLIS, Jan. 06, 2022 (GLOBE NEWSWIRE) — Northern Technologies International Corporation (NASDAQ: NTIC), a leading developer of corrosion inhibiting products and services, as well as bio-based and biodegradable polymer resin compounds, today reported its financial results for the first quarter of fiscal 2022. First quarter fiscal 2022 financial and operating highlights include (with growth rates on a fiscal year-over-year basis):Consolidated net sales increased 42.4% to a record $18,193,000 ZERUST® net sales increased 41.1% to $14,424,000 ZERUST® oil and gas net sales increased 72.7% to $972,000 NTIC China net sales decreased 10.7% to $4,058,000 Natur-Tec® product net sales increased 47.3% to $3,770,000 Joint venture operating income decreased 16.7% to $2,634,000 Net income attributable to NTIC increased to $4,494,000, compared...

Continue reading

MICA Announces $17 Million Dividend

$700 Million Returned to Policyholders Since 1988 PHOENIX, Jan. 06, 2022 (GLOBE NEWSWIRE) — The Mutual Insurance Company of Arizona (MICA) today announced that its Board of Trustees has declared a policyholder dividend of $17 million to be allocated among participating policyholders who are current MICA members as of December 31, 2021. This dividend is derived from a combination of favorable claims experience and strong investment performance. “As a physician-owned and directed mutual insurance company, MICA is able to return funds to our members whenever results are favorable. This year’s dividend exemplifies MICA’s financial strength and dedication to its mission of protecting and defending the practice of medicine,” said MICA CEO James F. Carland, MD. Following the February 2022 dividend distribution, MICA will have returned...

Continue reading

Entourage Health Posts New Year 2022 Shareholder Newsletter

TORONTO, Jan. 06, 2022 (GLOBE NEWSWIRE) — Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands issued an open letter to shareholders today to provide a recap of its corporate and operational achievements attained over the past year, and an overview of what is expected in 2022. The Company overview and Shareholder Newsletter is posted on Entourage’s website here. To access our corporate video, visit us here and to access our latest investor presentation and corporate deck here. About Entourage Health Corp. Entourage Health Corp. (formerly WeedMD Inc.) is the publicly traded parent company of WeedMD RX Inc. and CannTx Life Sciences Inc., licence holders producing and distributing cannabis...

Continue reading

FTC Solar to Present at 24th Annual Needham Virtual Growth Conference

AUSTIN, Texas, Jan. 06, 2022 (GLOBE NEWSWIRE) — FTC Solar, Inc. (Nasdaq: FTCI), a fast-growing global provider of solar tracker systems, software and engineering services, today announced that its Chief Executive Officer Sean Hunkler is scheduled to present at the 24th Annual Needham Virtual Growth Conference on Tuesday, January 11, 2022 at 5:00 p.m. Eastern Time. A live webcast and replay of this presentation will be accessible from the Events section of FTC Solar’s website at www.ftcsolar.com. About FTC Solar Inc.Founded in 2017 by a group of renewable energy industry veterans, FTC Solar is a fast-growing, global provider of solar tracker systems, technology, software, and engineering services. Solar trackers significantly increase energy production at solar power installations by dynamically optimizing solar panel orientation...

Continue reading

VBL Therapeutics to Present at H.C. Wainwright BioConnect Virtual Conference

TEL AVIV, Israel and NEW YORK, Jan. 06, 2022 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT), a clinical stage biotechnology company developing first-in-class therapeutics for difficult-to-treat malignant solid tumors and immune-inflammatory indications, today announced that Dror Harats, M.D., Chief Executive Officer of VBL Therapeutics, will present a corporate overview at the H.C. Wainwright BioConnect Virtual Conference being held on January 10 – 13, 2022. H.C. Wainwright BioConnect Virtual ConferenceDate: Monday, January 10th, 2022 Time: 7:00 a.m. ET Format: Corporate Presentation Webcast: https://journey.ct.events/view/71cf7592-8931-4425-838e-3a61e0811eec A link to this webcast will be available on the Events and Presentations page of the Investors section on the Company’s website at www.vblrx.com. About VBL TherapeuticsVascular...

Continue reading

Stryker announces definitive agreement to acquire Vocera Communications

Kalamazoo, Michigan, Jan. 06, 2022 (GLOBE NEWSWIRE) — Stryker (NYSE: SYK) announced today a definitive merger agreement to acquire all of the issued and outstanding shares of common stock of Vocera Communications, Inc. (NYSE: VCRA) for $79.25 per share, or a total equity value of approximately $2.97 billion and a total enterprise value of approximately $3.09 billion (including convertible notes). Vocera, which was founded in 2000, has emerged as a leading platform in the digital care coordination and communication category. The importance of this growing segment has continued to expand throughout the pandemic as it aims to reduce cognitive overload for caregivers and enables them to deliver the best patient care possible. Vocera brings a highly complementary and innovative portfolio to Stryker’s Medical division that will address...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.